keyword
https://read.qxmd.com/read/38240217/chest-ct-at-x-ray-dose-using-a-noise-mitigating-weighted-projection-the-thoracic-tomogram-diagnostic-performance-for-pneumonia-detection-in-hemato-oncology-patients
#21
JOURNAL ARTICLE
Felipe Sanchez Tijmes, Sonja Kandel, John Kavanagh, Sean Carey, Mary May, Shiyi Chen, Jonas Mattsson, Patrik Rogalla
PURPOSE: To compare the diagnostic performance of a thick-slab reconstruction obtained from an ultra-low-dose CT (termed thoracic tomogram) with standard-of-care low-dose CT (SOC-CT) for rapid interpretation and detection of pneumonia in hemato-oncology patients. METHODS: Hemato-oncology patients with a working diagnosis of pneumonia underwent an SOC-CT followed by an ultra-low-dose CT, from which the thoracic tomogram (TT) was reconstructed. Three radiologists evaluated the TT and SOC-CT in the following categories: (I) infectious/inflammatory opacities, (II) small airways infectious/inflammatory changes, (III) atelectasis, (IV) pleural effusions, and (V) interstitial abnormalities...
January 19, 2024: Canadian Association of Radiologists Journal
https://read.qxmd.com/read/38227814/evaluating-testicular-tissue-for-future-autotransplantation-focus-on-cancer-cell-contamination-and-presence-of-spermatogonia-in-tissue-cryobanked-for-boys-diagnosed-with-a-hematological-malignancy
#22
JOURNAL ARTICLE
Dhoha Kourta, Alessandra Camboni, Pascale Saussoy, Marc Kanbar, Jonathan Poels, Christine Wyns
STUDY QUESTION: What is the contamination rate by cancer cells and spermatogonia numbers in immature testicular tissue (ITT) harvested before the start of gonadotoxic therapy in boys with a hematological malignancy? SUMMARY ANSWER: Among our cohort of boys diagnosed with acute lymphoblastic leukemia (ALL) and lymphomas, 39% (n = 11/28) had cancer cells identified in their tissues at the time of diagnosis and all patients appeared to have reduced spermatogonia numbers compared to healthy reference cohorts...
March 1, 2024: Human Reproduction
https://read.qxmd.com/read/38201282/deciphering-acute-myeloid-leukemia-associated-transcription-factors-in-human-primary-cd34-hematopoietic-stem-progenitor-cells
#23
REVIEW
Sophie Kreissig, Roland Windisch, Christian Wichmann
Hemato-oncological diseases account for nearly 10% of all malignancies and can be classified into leukemia, lymphoma, myeloproliferative diseases, and myelodysplastic syndromes. The causes and prognosis of these disease entities are highly variable. Most entities are not permanently controllable and ultimately lead to the patient's death. At the molecular level, recurrent mutations including chromosomal translocations initiate the transformation from normal stem-/progenitor cells into malignant blasts finally floating the patient's bone marrow and blood system...
December 29, 2023: Cells
https://read.qxmd.com/read/38169831/treating-deep-venous-thrombosis-in-a-background-of-crohn-s-disease-a-clinical-conundrum
#24
Gurinder Singh, Keerthana Panchagnula, Paavan Desai, Dhruvish Mistry, Aakash Baskar, Ashima Gupta, Kamya Mehta, Yashash Pathak
Deep venous thrombosis (DVT) commonly affects the lower extremities, often as a result of prolonged immobilization. However, upper limb DVT is an atypical presentation, typically associated with risk factors such as the use of a peripherally inserted central catheter (PICC) line. This case report describes an uncommon case of DVT management in a patient with Crohn's disease, a condition more frequently characterized by painful lower gastrointestinal symptoms and chronic diarrhea. A 22-year-old male with a history of Crohn's disease developed swelling and purplish discoloration at the brachial site of a PICC line site...
December 2023: Curēus
https://read.qxmd.com/read/38152792/conjunctival-marginal-zone-lymphoma-in-a-patient-with-neurofibromatosis-type-1-a-case-report
#25
Chrysoula Florou, Evaggelia Aissopou, Evangelia Papakonstantinou, Ilias Georgalas, Konstantinos Droutsas
We present a case of painless bulbar conjunctival mass due to B-cell non-Hodgkin lymphoma (NHL), without systemic involvement, in a 76-year-old man. Following an excision biopsy, histopathologic examination and immunohistochemistry confirmed the diagnosis, prompting a referral for hemato-oncological assessment. The patient underwent comprehensive laboratory and imaging scans, subsequently receiving combined chemo-immunotherapy that resulted in complete remission to date. This case is reported as it is crucial to recognize that a conjunctival insult might emerge in neurofibromatosis type 1 (NF1) patients...
November 2023: Curēus
https://read.qxmd.com/read/38134481/attitudes-of-healthcare-professionals-and-drug-regulators-about-progression-free-survival-as-endpoint-in-the-advanced-cancer-setting
#26
JOURNAL ARTICLE
Douwe Postmus, Saskia Litiere, Jan Bogaerts, Jurjen Versluis, Jan J Cornelissen, Francesco Pignatti
PURPOSE: To describe the attitudes of healthcare professionals and drug regulators about progression-free survival (PFS) as efficacy endpoint in clinical trials with patients with advanced cancer and to explore to what extent these attitudes influence the willingness to trade between PFS and toxicity. METHODS: Cross-sectional survey with regulators from the European Medicines Agency (EMA), and healthcare professionals (HCP) from the "Stichting Hemato-Oncologie voor Volwassenen Nederland" (HOVON) collaborative group and the European Organisation for Research and Treatment of Cancer (EORTC)...
December 15, 2023: European Journal of Cancer
https://read.qxmd.com/read/38099388/managing-acute-covid-19-in-immunocompromised-pediatric-patients
#27
JOURNAL ARTICLE
Federico Mercolini, Nicoletta Abram, Simone Cesaro
INTRODUCTION: SARS-CoV-2 infection is a potentially life-threatening infection in immunocompromised pediatric patients and its management has rapidly evolved during the pandemic. For the control of SARS-CoV-2 infection, over time, the scenario changed for the better with the introduction of specific treatments such as antiviral drugs, vaccines and monoclonal antibodies together with drugs blocking the inflammatory cytokine cascade and improvements of supportive care. AREAS COVERED: the paper discusses the therapeutic strategies to apply for patients affected by COVID-19 in the pediatric population, with a focus on the immunocompromised patients...
December 15, 2023: Expert Review of Clinical Immunology
https://read.qxmd.com/read/38085494/burden-of-herpes-zoster-in-individuals-with-immunocompromised-conditions-and-autoimmune-diseases-in-the-republic-of-korea-a-nationwide-population-based-database-study
#28
JOURNAL ARTICLE
Jing Chen, Ju-Young Shin, Sumitra Shantakumar, Sungho Bea, Byong Duk Ye, Dong-Gun Lee, Hyungwoo Kim, Won Suk Choi, Iain Kaan
INTRODUCTION: To estimate herpes zoster (HZ) incidence rate (IR) and economic burden in individuals with immunocompromised conditions and autoimmune diseases (IC/AID) in the Republic of Korea (ROK). METHODS: The nationwide Health Insurance Review and Assessment Service database was used to identify HZ cases from 2016 to 2020 in ROK. HZ and non-HZ IC/AID cases were matched 1:3 using age, sex, institution, Charlson comorbidity index, IC/AID, and index date. Annual HZ IRs/1000 persons and 1-year HZ-associated all-cause direct medical costs for IC/AID cases were calculated...
December 12, 2023: Infectious Diseases and Therapy
https://read.qxmd.com/read/38060068/rsv-vaccination-strategies-for-high-risk-patients-2023-a-collaborative-position-paper-by-leading-german-medical-societies-and-organizations
#29
REVIEW
Marylyn Addo, Oliver Cornely, Michael Denkinger, Georg Ertl, Susanne Herold, Mathias Pletz, Gernot Rohde, Tobias Welte, Wolfram Windisch, Martin Witzenrath
Respiratory syncytial virus (RSV) inflicts severe illness and courses of infections not only in neonates, infants, and young children, but also causes significant morbidity and mortality in older adults and in people with immunosuppression, hemato-oncologic disease, chronic lung disease, or cardiovascular disease. In June and August 2023, effective vaccines against RSV were approved for the first time by the European Medicines Agency (EMA) for the EU. The respective pivotal studies showed a very high efficacy of the vaccine in preventing severe RSV-associated respiratory infections...
December 7, 2023: Infection
https://read.qxmd.com/read/38010420/-multimodal-ultrasound-techniques-for-the-differential-diagnosis-of-splenic-lesions-a%C3%A2-diagnostic-challenge
#30
REVIEW
Konrad Friedrich Stock, Julia Slotta-Huspenina, Hajo Findeisen, Christian Görg
BACKGROUND: Splenic tumors are rare and can pose a differential diagnostic challenge, especially as an incidental imaging finding. Due to a lack of large scale biopsy studies the available literature is limited with respect to clear imaging criteria for dignity. OBJECTIVE: The present work is intended to show the chances of a targeted elicitation of the medical history as well as the possibilities and limitations of multimodal sonography in order to achieve the correct diagnosis of a splenic lesion using simple and gentle methods...
November 27, 2023: Chirurgie (Heidelb)
https://read.qxmd.com/read/37981801/a-need-for-a-novel-survival-risk-scoring-system-for-intensive-care-admissions-due-to-sepsis-in-pediatric-hematology-oncology-patients
#31
JOURNAL ARTICLE
Talya Wittmann Dayagi, Ronit Nirel, Galia Avrahami, Shira Amar, Sarah Elitzur, Salvador Fisher, Gil Gilead, Oded Gilad, Tracie Goldberg, Shai Izraeli, Gili Kadmon, Eytan Kaplan, Aviva Krauss, Orli Michaeli, Jerry Stein, Orna Steinberg-Shemer, Hannah Tamary, Osnat Tausky, Helen Toledano, Avichai Weissbach, Joanne Yacobovich, Asaf D Yanir, Jessica Zon, Elhanan Nahum, Shlomit Barzilai-Birenboim
Background: Children with hemato-oncological diseases or following stem cell transplantation (SCT) are at high risk for life-threatening infections; sepsis in this population constitutes a substantial proportion of pediatric intensive care unit (PICU) admissions. The current pediatric prognostic scoring tools to evaluate illness severity and mortality risk are designed for the general pediatric population and may not be adequate for this vulnerable subpopulation. Methods: Retrospective analysis was performed on all PICU admissions for sepsis in children with hemato-oncological diseases or post-SCT, in a single tertiary pediatric hospital between 2008 and 2021 ( n  = 233)...
November 19, 2023: Journal of Intensive Care Medicine
https://read.qxmd.com/read/37947136/pain-monitoring-app-leads-to-less-pain-in-children-with-cancer-at-home-results-of-a-randomized-controlled-trial
#32
JOURNAL ARTICLE
Julia D H P Simon, Sasja A Schepers, Marloes van Gorp, Erna M C Michiels, Marta Fiocco, Martha A Grootenhuis, Wim J E Tissing
BACKGROUND: The authors developed a pain monitoring app offering educational information, and real-time health care professional feedback on clinically significant pain (>4 numeric rating scale [NRS]-11) for children with cancer to reduce pain at home. METHODS: This monocenter, nonblinded randomized controlled trial enrolled Dutch children (0-18 years old) receiving cancer treatment (≥3 months after diagnosis, ≥2 months treatment remaining)...
November 10, 2023: Cancer
https://read.qxmd.com/read/37944697/dual-anti-viral-treatment-for-persistent-covid-19-in-immunocompromised-hemato-oncological-patients-is-associated-with-a-favorable-prognosis-and-minor-side-effects
#33
JOURNAL ARTICLE
Suzy E Meijer, Ora Halutz, Amos Adler, Katya Levytskyi, Luba Tau, Michal Dekel, Ronit Cohen-Poradosu, Evgene Katchman, David Shasha, Jacob Ablin, Guy Choshen, Giris Jacob, Asaf Wasserman, Merav Ingbir, Yael C Cohen, Chava Perry, Ron Ram, Yair Herishanu, Yael Bar On, Elma van Thijn, Natalie Rutsinsky, Sheri Harari, Adi Stern, Ronen Ben-Ami, Yael Paran
In hemato-oncological patients, COVID-19 can present as a persistent infection with ongoing symptoms and viral replication over a prolonged period of time. Data are scarce on the preferred treatment options for these patients. We describe our experience with a five-day course of dual anti-viral treatment with remdesivir and nirmatrelvir/ritonavir for hemato-oncological immunocompromised patients with persistent COVID-19. Fifteen patients with a history of lymphoma, CLL, and MM were included. Eight were male, median age was 74...
November 7, 2023: Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy
https://read.qxmd.com/read/37904468/unmeasurable-capillary-c-reactive-protein-as-one-of-the-diagnostic-clues-of-severe-hematological-pathologies-in-children-in-primary-settings-case-series
#34
JOURNAL ARTICLE
Barbora Piteková, Jakub Zieg, Patrik Konopásek, Ladislav Turecký, Marcel Brenner, Jakub Gécz
RATIONALE: The manuscript aimed to show that an unmeasurable capillary C-reactive protein (CRP) should be a red flag that can indicate a possible severe hematological pathology. PATIENTS CONCERNS AND DIAGNOSES: The authors present 3 case reports of children with fever examined at the pediatric emergency department. Fever is among the most frequently exhibited symptoms of acute pediatric infectious diseases. However, sometimes fever can be the manifestation of other serious noninfectious diseases...
October 27, 2023: Medicine (Baltimore)
https://read.qxmd.com/read/37890142/optimizing-platelet-transfusion-through-a-personalized-deep-learning-risk-assessment-system-for-demand%C3%A2-management
#35
JOURNAL ARTICLE
Merlin Engelke, Cynthia Sabrina Schmidt, Giulia Baldini, Vicky Parmar, René Hosch, Katarzyna Borys, Sven Koitka, Amin T Turki, Johannes Haubold, Peter A Horn, Felix Nensa
Platelet demand management (PDM) is a resource-consuming task for physicians and transfusion managers of large hospitals. Inpatient numbers and institutional standards play significant roles in PDM. However, reliance on these factors alone commonly results in platelet shortages. Using data from multiple sources, we developed, validated, tested, and implemented a patient-specific approach to support PDM that uses a deep learning-based risk score to forecast platelet transfusions for each hospitalized patient in the next 24 hours...
December 28, 2023: Blood
https://read.qxmd.com/read/37877352/timing-of-bnt162b2-vaccine-prior-to-covid-19-infection-influence-disease-severity-in-patients-with-hematologic-malignancies-results-from-a-cohort-study
#36
JOURNAL ARTICLE
Odit Gutwein, Katrin Herzog Tzarfati, Arie Apel, Naomi Rahimi-Levene, Levy Ilana, Tamar Tadmor, Maya Koren-Michowitz
The COVID-19 pandemic continues to pose challenges to the treatment of hemato-oncology patients. Emergence of COVID-19 variants, availability of vaccine boosters and antiviral treatments could impact their outcome. We retrospectively studied patients with hematologic malignancies and confirmed COVID-19 during the Omicron outbreak. Of 116 evaluated patients, 16% developed severe or critical COVID-19. Diagnosis of chronic lymphocytic leukemia (CLL) was significantly associated with severe COVID-19 (p = 0...
November 2023: Cancer Medicine
https://read.qxmd.com/read/37805604/accuracy-of-pancreatic-stone-protein-for-diagnosis-of-sepsis-in-children-admitted-to-pediatric-intensive-care-or-high-dependency-care-a-pilot-study
#37
JOURNAL ARTICLE
Gabriella Bottari, Mariangela Caruso, Emanuel Paionni, Maia De Luca, Lorenza Romani, Mara Pisani, Annalisa Grandin, Livia Gargiullo, Giorgio Zampini, Chiara Gagliardi, Danilo Alunni Fegatelli, Annarita Vestri, Laura Lancella, Ottavia Porzio, Andrea Onetti Muda, Alberto Villani, Marta Ciofi Degli Atti, Massimiliano Raponi, Corrado Cecchetti
BACKGROUND: Pancreatic Stone Protein (PSP) is one of the most promising diagnostic and prognostic markers. The aim of the study was to assess the accuracy of PSP, compared to C-Reactive Protein (CRP), and Procalcitonin (PCT) for sepsis diagnosis in pediatric patients. Furthermore, we explored the correlation of PSP levels with sepsis severity and organ failure measured with PELOD-2 score. METHODS: Forty pediatric patients were enrolled following admission to pediatric intensive care, high dependency care or pediatric ward...
October 7, 2023: Italian Journal of Pediatrics
https://read.qxmd.com/read/37783588/new-treatment-opportunities-for-older-patients-with-acute-myeloid-leukemia-and-the-increasing-importance-of-frailty-assessment-an-oncogeriatric-perspective
#38
REVIEW
Benno Diekmann, Marjolijn Timmerman, Liesbeth Hempenius, Eric van Roon, Bas Franken, Mels Hoogendoorn
With the introduction of targeted chemotherapy drugs, a new age of treatment for acute myeloid leukemia (AML) has begun. The promotion of the azacitidine+venetoclax combination regimen to first line of treatment in patients deemed ineligible for intensive chemotherapy marks the first of many novel combination regimens becoming part of national treatment guidelines. We review recent phase II and III clinical trials and conclude that these novel regimens offer significant increases in response rates, remission rates, and overall survival...
September 30, 2023: Journal of Geriatric Oncology
https://read.qxmd.com/read/37761440/correlation-of-speckle-tracking-echocardiography-with-traditional-biomarkers-in-predicting-cardiotoxicity-among-pediatric-hemato-oncology-patients-a-comprehensive-evaluation-of-anthracycline-dosages-and-treatment-protocols
#39
JOURNAL ARTICLE
Andrada Mara Ardelean, Ioana Cristina Olariu, Raluca Isac, Ruxandra Jurac, Cristiana Stolojanu, Mircea Murariu, Ana-Olivia Toma, Laurentiu Braescu, Adelina Mavrea, Gabriela Doros
Speckle tracking-echocardiography (STE) is a novel non-invasive imaging tool capable of quantifying myocardial deformation, and thus holds promise in detecting early subclinical myocardial injury. This study aimed to evaluate the correlation of STE with traditional biomarkers in predicting anthracycline-induced cardiotoxicity in the context of varying dosages and treatment protocols in pediatric hemato-oncology patients. We conducted a retrospective study involving pediatric hemato-oncology patients undergoing anthracycline-based chemotherapy...
August 30, 2023: Children
https://read.qxmd.com/read/37736806/crispr-cas9-system-a-novel-and-promising-era-of-genotherapy-for-beta-hemoglobinopathies-hematological-malignancy-and-hemophilia
#40
REVIEW
Abdulfatah M Alayoubi, Zakaria Y Khawaji, Mohammed A Mohammed, François E Mercier
Gene therapy represents a significant potential to revolutionize the field of hematology with applications in correcting genetic mutations, generating cell lines and animal models, and improving the feasibility and efficacy of cancer immunotherapy. Compared to different genetic engineering tools, clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR-associated protein 9 (Cas9) emerged as an effective and versatile genetic editor with the ability to precisely modify the genome. The applications of genetic engineering in various hematological disorders have shown encouraging results...
September 22, 2023: Annals of Hematology
keyword
keyword
46772
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.